Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Consensus Rating of “Hold” from Analysts

Phibro Animal Health Corporation (NASDAQ:PAHC) has received an average rating of “Hold” from the five ratings firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $42.50.

A number of equities research analysts have commented on PAHC shares. Citigroup dropped their price objective on shares of Phibro Animal Health from $62.00 to $44.00 and set a “neutral” rating on the stock in a research report on Thursday, May 14th. Wall Street Zen lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Weiss Ratings lowered shares of Phibro Animal Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, June 15th. Finally, Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 21st.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $34.36 on Friday. The business has a 50-day moving average of $33.34 and a 200 day moving average of $42.76. The company has a debt-to-equity ratio of 1.97, a current ratio of 3.17 and a quick ratio of 1.26. Phibro Animal Health has a 12 month low of $28.25 and a 12 month high of $60.08. The stock has a market capitalization of $1.39 billion, a price-to-earnings ratio of 14.75, a price-to-earnings-growth ratio of 0.48 and a beta of 0.46.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Wednesday, September 2nd will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, September 2nd. Phibro Animal Health’s dividend payout ratio (DPR) is presently 20.60%.

Institutional Investors Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Cvfg LLC acquired a new stake in shares of Phibro Animal Health during the 1st quarter worth about $2,962,000. Advisors Preferred LLC acquired a new stake in shares of Phibro Animal Health during the 1st quarter worth $2,931,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in shares of Phibro Animal Health in the 1st quarter worth about $1,759,000. Renaissance Technologies LLC raised its holdings in Phibro Animal Health by 5.8% in the first quarter. Renaissance Technologies LLC now owns 576,735 shares of the company’s stock valued at $31,899,000 after buying an additional 31,435 shares during the period. Finally, Capricorn Fund Managers Ltd raised its stake in shares of Phibro Animal Health by 45.1% in the 1st quarter. Capricorn Fund Managers Ltd now owns 267,045 shares of the company’s stock valued at $14,770,000 after acquiring an additional 82,944 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.